Welcome to our dedicated page for Alto Ingredients SEC filings (Ticker: ALTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alto Ingredients, Inc.'s SEC filings document operating results, governance matters and material events for a Nasdaq-listed producer and distributor of specialty alcohols, renewable energy products and essential ingredients. Current reports furnish earnings releases and financial-condition disclosures, along with board composition changes, annual meeting voting results and a completed Nasdaq continued-listing compliance matter.
Definitive proxy materials describe stockholder voting, board elections and governance procedures. The filing record also reflects operating initiatives discussed by the company, including revenue diversification, renewable fuel exports, plant efficiency, cost reductions, asset optimization and integrated liquid carbon dioxide operations.
Alto Ingredients, Inc. director Nathan E. Gilbert purchased additional common stock. On 2026-08-11, he bought 50,000 shares at a weighted average price of $4.15 per share, with individual trade prices ranging from $4.13 to $4.1599. Following this open-market purchase, he directly holds 856,393 common shares. In addition, there are 31,200 shares reported as held indirectly by spouse.
Alto Ingredients, Inc. entered into an At-The-Market Issuance Sales Agreement on August 5, 2026 with Craig-Hallum Capital Group LLC as designated sales agent, and The Benchmark Company, LLC and H.C. Wainwright & Co., LLC as additional agents. The program allows the company to offer and sell shares of common stock with an aggregate offering price of up to $50.0 million from time to time.
The shares will be issued under an effective Form S-3 shelf registration and a related prospectus supplement, with sales deemed “at the market offerings” under Rule 415. Alto expects to use any net proceeds for general corporate purposes, including working capital and capital expenditures. The agents will earn a 3.0% commission on gross proceeds, and the company is not obligated to sell, with no assurance that any shares will be sold before the agreement terminates.
Alto Ingredients reported a strong turnaround for the quarter ended June 30, 2026. Net sales rose to $245.7 million, up 12.5% from $218.4 million a year earlier, as higher average alcohol and essential ingredient prices more than offset modest volume changes. Gross margin improved to 6.8% from a negative 0.9%, driving net income of $11.7 million versus an $11.0 million loss, and net income attributable to common stockholders of $11.4 million, or $0.15 per diluted share.
The company generated $23.7 million of Adjusted EBITDA in the quarter and $28.3 million year‑to‑date, aided by $5.1 million in transferable tax credits, net, and lower interest expense from reduced debt. Pekin Campus was the main earnings driver, while Western production and corporate operations also posted positive gross profit.
Liquidity remained solid with $24.0 million in cash and $110.4 million of working capital at June 30, 2026, plus $41.3 million of unused capacity on Kinergy’s credit line and $65.0 million available for Orion term‑loan capital projects. The Magic Valley, Idaho plant remains cold‑idled due to margin pressure, though it continues to provide terminaling services.
Alto Ingredients reported much stronger results for the quarter ended June 30, 2026. Net sales were $245,698 thousand, up from $218,436 thousand a year earlier. Gross profit was $16.6 million, versus a gross loss in 2025, and Adjusted EBITDA was $23.7 million, both sharply higher year over year. Net income attributable to common stockholders was $11.4 million, or $0.15 per share, compared with a net loss of $11,312 thousand.
For the six months ended June 30, 2026, net sales were $470,378 thousand and net income attributable to common stockholders was $15,345 thousand, compared with a loss of $23,303 thousand in the prior-year period. Management noted this was the fourth consecutive quarter with positive gross profit, income from operations, net income and Adjusted EBITDA, supported by diversification across renewable fuels, specialty alcohols and essential ingredients and by earnings from Section 45Z tax credits. Transferable tax credits, net, contributed $5,112 thousand in Q2 and $9,012 thousand year to date. Cash and cash equivalents were $24.0 million at June 30, 2026, with borrowing availability of $106 million. The company also established a $50 million at-the-market equity program to provide additional financial flexibility for high-return organic projects.
Alto Ingredients, Inc. is establishing an at-the-market equity program to issue and sell up to $50.0 million of common stock under an existing $150.0 million shelf registration. Sales will be made from time to time through Craig-Hallum (as designated agent), The Benchmark Company and H.C. Wainwright, which will receive a 3.0% commission on gross proceeds.
The company’s common stock last traded at $5.29 on August 4, 2026. Based on an assumed sale of 9,451,795 shares at that price, shares outstanding would increase from 77,567,564 to 87,019,359, and net tangible book value per share would rise from $2.88 to $3.12, implying illustrative dilution of $2.17 per share to new investors.
Net proceeds, if any, will be used for general corporate purposes, including working capital and capital expenditures. Alto is a U.S. producer and distributor of specialty alcohols, renewable fuels and essential ingredients, with annual alcohol production capacity of 330 million gallons and over 1.2 million tons of essential ingredients marketed in 2025. The company is a smaller reporting company and does not expect to pay cash dividends on common stock for the foreseeable future.
BlackRock, Inc. reports beneficial ownership of common stock of Alto Ingredients, Inc. as of June 30, 2026. BlackRock beneficially owns 5,359,099 shares of Alto Ingredients common stock, representing 6.9% of the outstanding class.
BlackRock has sole voting power over 5,302,063 shares and sole dispositive power over 5,359,099 shares, with no shared voting or dispositive power. The shares are held across various clients and funds; while these underlying investors may receive dividends or sale proceeds, no single underlying holder has an interest exceeding five percent of Alto Ingredients’ total outstanding common shares.
Nury Dianne S. reported acquisition or exercise transactions in this Form 4 filing.
Alto Ingredients, Inc. director Dianne S. Nury received a grant of 23,605 shares of common stock. The award was recorded at a price of $0.00 per share, reflecting a compensation-related stock grant rather than an open-market purchase. Following this grant, her direct ownership increased to 241,015 common shares.
Alto Ingredients, Inc. director Nathan E. Gilbert reported an equity award and updated his holdings of common stock. He received a grant of 31,652 shares of common stock at a price of $0.0000 per share, characterized as a grant, award, or other acquisition. Following this grant, his direct holdings increased to 806,393 shares of common stock. The filing also reports 31,200 shares of common stock held indirectly through his spouse, reflecting existing ownership rather than a new transaction.
Tank Alan Robert reported acquisition or exercise transactions in this Form 4 filing.
Alto Ingredients, Inc. director Alan Robert Tank reported receiving a grant of 23,605 shares of Common Stock. The award was recorded at a price of $0.00 per share, indicating it is a compensation-related grant rather than an open-market purchase. Following this non-derivative award, he directly holds 60,271 shares of Alto Ingredients common stock.
Alto Ingredients, Inc. director Maria G. Gray reported receiving a grant of 23,605 shares of Common Stock on June 23, 2026. The shares were acquired at a stated price of $0.0000 per share as a grant, award, or other acquisition rather than an open-market purchase. Following this equity award, Gray directly owns 179,229 shares of Alto Ingredients common stock.